Ralph Schiess
Förmögenhet: 190 $ per 2026-05-31
Förmögenhet: 190 $ per 2026-05-31
Ralph Schiess was the founder of Proteomedix AG, founded in 2010, and held the title of Chief Executive Officer from 2023 to 2025.
Former job includes Chief Executive & Science Officer at Onconetix, Inc. from 2024 to 2025.
Education includes graduate degree from the University of Zurich and doctorate from the Swiss Federal Institute of Technology.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ONCONETIX INC 0,01 % | 2026-03-13 | 158 ( 0,01 % ) | 190 $ | 2026-05-31 |
| Företag | Position | Slut |
|---|---|---|
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Verkställande Direktör | 2025-05-31 |
| ONCONETIX, INC. | Verkställande Direktör | 2025-02-24 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Health Technology |
Onconetix, Inc.
Onconetix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs and diagnostic test for cancers | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån